Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel nontaxane tubulin-polymerizing epothilone lactam discovered at BMS

Nov. 22, 2000

NCI-EORTC-AACR highlights: E-7070 progresses to phase II based on phase I findings

Nov. 22, 2000

No consistent PKC inhibition or significant MDR reversal in melanoma patients treated with CGP-41251

Nov. 22, 2000

Nonanticoagulant heparin derivative designed to exert antiangiogenic activity

Nov. 22, 2000

Novel nucleoside transport inhibitors may overcome limitations of dipyridamole

Nov. 22, 2000

First clinical trial results with Oxford Biomedica's MetXia reported

Nov. 22, 2000

Ligand's Targretin recommended for approval by CPMP

Nov. 22, 2000

Photogen Technologies' PH-10 shows promise for PDT in preclinical studies

Nov. 22, 2000

Biological profile of KF-58333, a new hsp90 antagonist derived from radicicol

Nov. 21, 2000

Cytotoxic hydrazones with novel mechanism of action presented at recent cancer meeting

Nov. 21, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...